Last reviewed · How we verify

Zydelig

University of Maryland, Baltimore · FDA-approved active Small molecule

At a glance

Generic nameZydelig
Also known asIdelalisib
SponsorUniversity of Maryland, Baltimore
TargetDNA-dependent protein kinase catalytic subunit, Phosphatidylinositol 3-kinase catalytic subunit type 3, Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform
ModalitySmall molecule
Therapeutic areaOncology
PhaseFDA-approved

Approved indications

Common side effects

Serious adverse events

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results